post-bg-583
calendary August 8, 2022

Inventory shortage or risk of inventory shortage - update of legislation. Part 1

In the spring of 2022, in connection with the introduction of economic restrictive measures against the Russian Federation, the Government of the Russian Federation issued Resolutions regarding the specifics of the circulation of drugs in the event of a inventory shortage or the risk of a inventory shortage (No. 593), as well as on the specifics of introducing changes to the documents contained in the registration dossier for a registered medicinal product in case of a inventory shortage or risk of a inventory shortage (No. 440).

Inventory shortage- absence of the necessary goods (medicinal products) in the pharmacy (pharmacy institution).

Inventory shortage or the risk of drug inventory shortage with the indication the names (international non-proprietary, or chemical, or their grouping forms), dosages, the presence of therapeutic analogues and in other cases of circulation of the medicinal product, are determined by the interdepartmental commission.

The Interdepartmental Commission consists of representatives of the Ministry of Health of the Russian Federation, the Ministry of Industry and Trade of the Russian Federation, the Federal Customs Service, the Federal Service for Surveillance in Healthcare and other interested federal executive bodies.

The decision of the interdepartmental commission is drawn up in a conclusion in the approved form, and information about the decisions of the interdepartmental commission is posted on the official website of the Ministry of Health of Russia.

Due to the possible risk of inventory shortage of some drugs, the concept of “therapeutic analogue” is introduced - a drug whose international non-proprietary name is registered in the Russian Federation, including the one that was previously registered in the Russian Federation and in respect of which a decision was made to cancel state registration in accordance with paragraphs 2 8 of Article 32 of the Federal Law "On the Circulation of Medicines", belonging to the same pharmacotherapeutic group, acting on the same biotarget (or its receptor) and used for one of the indications as the drug, in respect of which the interdepartmental commission has established a inventory shortage or risk its occurrence.

Therapeutic similarity is established by the interdepartmental commission.

Decree No. 593 is valid until December 31, 2023.


  1. Materials of the SCIENTIFIC-PRACTICAL CONFERENCE “MODERN APPROACHES TO THE EXAMINATION AND REGISTRATION OF MEDICINES” REGLEK — 2022
  2. Decree of the Government of the Russian Federation of 05.04.2022 N 593 "On the peculiarities of the circulation of medicinal products for medical use in the event of a inventory shortage or the risk of a inventory shortage in medicinal products in connection with the introduction of economic restrictive measures against the Russian Federation"
  3. Decree of the Government of the Russian Federation of March 23, 2022 N 440 "On approval of the specifics of making changes to the documents contained in the registration dossier for a registered medicinal product for medical use in the event of a inventory shortage or risk of a inventory shortage in medicinal products in connection with the introduction of restrictive economic measures against the Russian Federation character"
References:

More related posts

new-img-1

Control

Fine for spa resort in Yessentuki

Roszdravnadzor has imposed a fine of 130 thousand rubles on a spa resort in Yessentuki for improper storage of medical products…

03.03.2016
READ ARTICLE
new-img-2

Roszdravnadzor

Roszdravnadzor – patients’ rights

In 2015, Roszdravnadzor restored the rights of more than 460 thousand citizens to effective, accessible, and safe medical…

03.03.2016
READ ARTICLE
new-img-3

Regulation

The certification scheme for medical products hasn’t changed recently

Roszdravnadzor informs that the certification scheme for products in the Russian Federation is determined by Decree of the…

03.04.2016
READ ARTICLE
new-img-4

Control

Fines – Rostov region

In one and a half months of 2016, the Local Agency of Roszdravnadzor in Rostov Region imposed fines of the total amount of…

03.10.2016
READ ARTICLE
new-img-5

Control

Unregistered medical products

Two citizens were fined for selling unregistered medicinal products on the Internet in the Republic of Bashkortostan.

03.10.2016
READ ARTICLE
new-img-6

Control

Unscheduled inspection by roszdravnadzor

Roszdravnadzor started an unscheduled inspection of the Federal State-Funded Institution of Sverdlovsk Region Kirovgrad Central…

03.14.2016
READ ARTICLE
new-img-7

Medical Devices

International medical device regulators forum (IMDRF)

The delegation of the Federal Service for Surveillance in Healthcare headed by Mikhail Murashko, Head of Roszdravnadzor,…

03.17.2016
READ ARTICLE
new-img-8

Pharmaceuticals

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF”

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF” in which pills the metal wire was found.

05.18.2016
READ ARTICLE
new-img-9

Roszdravnadzor

Medical equipment stands idle in the Pskov region

Roszdravnadzor (RZN) statement: the expensive medical equipment for the total amount of 342 million rubles stands idle in…

05.19.2016
READ ARTICLE
new-img-10

Control

Hospital control Jewish autonomous region

Roszdravnadzor has audited the activity of the Regional Budgetary Public Health Facility “Central district hospital of Lenin”…

05.20.2016
READ ARTICLE